Meyers, Stephanie A.
Scheim, Ayden
Jain, Sonia
Sun, Xiaoying
Milloy, M. J.
DeBeck, Kora
Hayashi, Kanna
Garfein, Richard S.
Werb, Dan https://orcid.org/0000-0003-0614-9386
Funding for this research was provided by:
National Institute on Drug Abuse (DP2- DA040256-01, R37 DA019829, R01DA031074, U01DA038886, U01DA021525)
Canadian Institutes of Health Research (MSH-141971)
Article History
Received: 2 August 2018
Accepted: 15 November 2018
First Online: 4 December 2018
Ethics approval and consent to participate
: All participants provided consent prior to enrollment, and all study sites received ethical approval from their local institutional review boards (IRBs) []. PRIMER was approved as previously described by the University of California, San Diego Human Research Protection Program, the University of British Columbia-Providence Health Care Research Ethics Board, and Universidad Xochicalco School of Medicine IRB.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.